Truveta
Facts
- HQ
- Seattle area, Washington, US
- Sectors
- Hospitals and Health Care
- Founded
- 2020
- Employees
- 477
- Stage
- startup
Truveta Partners with Pfizer to Monitor COVID Vaccine and Therapy Safety Using Data from 20 U.S. Health Systems
Seattle-based health data company Truveta partnered with Pfizer to use its platform for monitoring COVID vaccine and therapy safety in the U.S., leveraging data from 20 health systems. Truveta also released data indicating women may be more prone to long COVID, aligning with earlier research.
Startups, superheroes, and the economy at a crossroads: Voices from Seattle's tech community
After holding the GeekWire Awards virtually for the past two years, there was a feeling of real catharsis Thursday evening as hundreds of people streamed through the doors of the Showbox Sodo in Seattle for our annual celebration of the Pacific Northwest's top tech startups, leaders, and innovations. For the finalists in the 2022 GeekWire Awards, recognition at the superhero-themed show came with the added bonus of knowing that their companies made it through a period of unprecedented challenge and change. But the week also brought a new sense of uncertainty about what's to come. [Related Post: 2022 GeekWire Awards…
Andreessen Horowitz, Madrona and other tech VCs ramp up bets on AI-driven biotech startups as founders from software enter life sciences
Tech venture capital firms like Andreessen Horowitz and Seattle’s Madrona Venture Group are increasingly investing in life-science startups that use AI, machine learning and data science to speed drug discovery and development. Investors are following founders who transitioned from software to biotech—such as Sujal Patel of Nautilus and Terry Myerson of Truveta—seeing reduced perceived risk and new opportunity at this intersection.
DexCare, Providence spinout led by CEO Derek Streat, raises $50M to expand patient-access platform
Seattle health-tech startup DexCare, spun out of Providence’s digital innovation group, raised $50 million to accelerate platform development and go-to-market expansion; its software manages health system capacity and patient appointment booking and is used by Providence, Kaiser Permanente, Mass General Brigham, Houston Methodist and others. The round follows a $20 million raise last March and was led by Transformation Capital, whose managing partner emphasized patient competition as a major hospital issue in 2022.
Truveta launches early health-data platform, signs Ochsner, Saint Luke’s and UnityPoint; funding nears $200M
Seattle startup Truveta launched an early version of its health data platform, added three provider partners and now says it has raised nearly $200 million in funding to aggregate clinical data across systems.
Microsoft invests in Seattle startup Truveta and partners to run health-data analyses on Azure
Seattle health-data startup Truveta will use Microsoft Azure under a new partnership and received an undisclosed Microsoft investment; the company aggregates de-identified data from 17 health systems representing about 15% of U.S. patients. Truveta, led by former Microsoft exec Terry Myerson, previously raised $95 million from healthcare partners including Providence and says the data will support research and care decisions, not targeted patient advertising.
Xealth, a Providence Spinout, Raises $24M to Expand Digital Health Platform and Workforce
Seattle-based Xealth, a Providence spinout that helps more than 20 hospital systems prescribe and monitor digital health tools, raised $24 million in new funding to expand its platform and double its 55-person workforce. The company integrates with major electronic health records, licenses its platform to hospital systems, and has onboarded services from over 50 digital health vendors.
Former Tech Leaders Join Biotech: Isilon Founder Sujal Patel, Ex-Microsoft Terry Myerson and Others Lead AI-Driven Life Sciences Startups
Several former software and tech executives are moving into biotech and life sciences startups, bringing AI, machine learning, and tech-style business models to companies that analyze proteins, microbes, and medical records. Their tech backgrounds are reshaping product development and funding approaches at firms such as Nautilus Biotechnology, Truveta, insitro and Viome.
Truveta raises $95M from 17 partner systems, gains access to >15% of U.S. patient records across 40 states
Seattle health-data startup Truveta raised $95 million in Series A funding from its 17 partner healthcare systems and added three new partners, giving it access to records covering more than 15% of U.S. patient care across 40 states. CEO Terry Myerson says the pooled data and insurance claims will let researchers and life sciences companies link treatments to outcomes to improve patient care and safety research.
Seattle Foundation CEO Tony Mestres to become president of health data startup Truveta in May
Tony Mestres will leave his role as president and CEO of the Seattle Foundation in May to become president of Truveta, a health data startup led by former Microsoft Windows chief Terry Myerson. Truveta, founded by 14 U.S. health systems to pool data and apply AI for medical research and equity analysis, appoints Mestres after his seven-year tenure at the Seattle Foundation.
Fourteen U.S. health systems form Seattle startup Truveta to pool de-identified data for AI-driven research
Fourteen U.S. health systems representing tens of millions of patients across 40 states formed Seattle startup Truveta to pool de-identified patient data and use AI to search for medical breakthroughs and detect healthcare inequities. Led by CEO Terry Myerson and governed by the participating systems, Truveta has 53 employees and says it will enable more statistically representative research populations while protecting patient privacy.
Terry Myerson launches Seattle health-data startup Truveta to develop patient-care innovations, pledges strict privacy
Terry Myerson, former head of Microsoft's Windows and Devices Group, launched Seattle-area health-data startup Truveta to use patient data for developing treatments and improving care while emphasizing strong privacy protections. The company has hired nearly 20 people, plans to grow, declined to disclose funding or ownership details, and signals collaborations with health systems such as Providence Health & Services.
